Chemical, biotechnology and pharmaceutical Books

Book SynopsisThis is your nation's history on drugsAmericans are stumbling through a world-historic drug binge. Opiates, amphetamines, benzodiazepines, marijuana, antidepressants, antipsychotics-across the board, consumption has shot up in the twenty-first century. At the same time, the United States is home to the largest prison system in the world, justified in part by a now zombified "war" on drugs. How did we get here?Quick Fixes blows away the pharmacological fog to take a sober look at how drugs have shaped American society. Though particularly acute in recent decades, the contradiction between America's passionate love for and intense hatred of these sub - stances has been one of its defining characteristics for over a century. Through nine chapters, each devoted to the modern history of a drug or class of drugs, Fong examines Americans' fraught relationship with psychoactive substances. As society changes, it produces different forms of stress, isolation, and alienation. These changes, in turn, affect the development and spread of medications and narcotics among the populace.By laying out the histories, functions, and experiences of our chemical com - forts, the hope is to help answer that ever-perplexing question: what does it mean to be an American?Trade ReviewProvocative, methodical, and righteously witty, Quick Fixes provides the fullest articulation I've seen of an argument often implied but rarely fleshed out: that 'drug problems' such as addiction and brutal drug wars are actually about capitalism rather than drugs. Under capitalism, Fong argues, drugs have been used to extract more labor from workers, to profit from workers' isolation and need for relief, and to police marginalized so-called 'surplus' populations. As a result both drug use and drug policing have become harmful compulsions. And because these compulsions are caused by capitalism, not drugs, we cannot free ourselves simply by ending the drug war. -- David Herzberg, author of White Market DrugsDrugs are deeply integrated into American capitalism, not just American culture. 'Profit wins in the end,' as Ben Fong says, but his clear, thoughtful, and troubling account improves the odds of the fight for better, longer lives. -- Craig Calhoun, coauthor of Degenerations of DemocracyWith drug use surging in the US, Ben Fong's fascinating look into America's relationship with psychoactive substances is unprecedented both in rigor and scope. It's a history you've never read before, and a desperately needed examination of where we are, how we got here, and why exactly we're all so blitzed. -- Amber A'Lee Frost, Chapo Trap House

Read more less

Book SynopsisStrictly off limits to the public, Plum Island is home to virginal beaches, cliffs, forests, ponds -- and the deadliest germs that have ever roamed the planet. Lab 257 blows the lid off the stunning true nature and checkered history of Plum Island. It shows that the seemingly bucolic island in the shadow of New York City is a ticking biological time bomb that none of us can safely ignore.Based on declassified government documents, in-depth interviews, and access to Plum Island itself, this is an eye-opening, suspenseful account of a federal government germ laboratory gone terribly wrong. For the first time, Lab 257 takes you deep inside this secret world and presents startling revelations on virus outbreaks, biological meltdowns, infected workers, the periodic flushing of contaminated raw sewage into area waters, and the insidious connections between Plum Island, Lyme disease, and the deadly West Nile virus. The book also probes what''s in store for Plum Isl

Read more less

Book SynopsisAt present India is a leading producer, distributer, and consumer of generic medicines. Tracing this development, Disparate Remedies explores the integrated histories of the medical market and industrially manufactured medicines in colonial and postcolonial India, engaging with the cultures of both consumption and production.Trade Review“Disparate Remedies demonstrates the eclecticism of every aspect of the drug trade, illustrating how a lack of legislation and regulation largely resulted in a ‘free-for-all’ in the making, supply, and sale of remedies with the consequent ubiquity of counterfeiting, adulteration, and supply of substandard medicines. The great contribution of this book is that it provides a longer historical perspective and narrative than many previous works, suggesting that the rapid rise of the pharmaceutical industry in India can only be understood by knowing its historical context.” Stuart Anderson, London School of Hygiene and Tropical Medicine

Read more less

Book SynopsisAt present India is a leading producer, distributer, and consumer of generic medicines. Tracing this development, Disparate Remedies explores the integrated histories of the medical market and industrially manufactured medicines in colonial and postcolonial India, engaging with the cultures of both consumption and production.Trade Review“Disparate Remedies demonstrates the eclecticism of every aspect of the drug trade, illustrating how a lack of legislation and regulation largely resulted in a ‘free-for-all’ in the making, supply, and sale of remedies with the consequent ubiquity of counterfeiting, adulteration, and supply of substandard medicines. The great contribution of this book is that it provides a longer historical perspective and narrative than many previous works, suggesting that the rapid rise of the pharmaceutical industry in India can only be understood by knowing its historical context.” Stuart Anderson, London School of Hygiene and Tropical Medicine

Read more less

Trade Review"A careful and penetrating piece of scholarship that makes an important contribution to the study of social and economic institutions."—Sheldon Krimsky, Tufts University "A careful and penetrating piece of scholarship that makes an important contribution to the study of social and economic institutions."—Sheldon Krimsky, Tufts University "Here is a dispassionate discussion of biotechnology—its beginnings and where it may lead. Dr. Kenney's analysis of the interrelations between corporate and university forces is thoughtful and comprehensive. The book, which may serve as a reference text, should provide the basis for the socioeconomic debate that will inevitably intensify with time."—Liebe F. Cavalieri, Sloan-Kettering Institute"Here is a dispassionate discussion of biotechnology—its beginnings and where it may lead. Dr. Kenney's analysis of the interrelations between corporate and university forces is thoughtful and comprehensive. The book, which may serve as a reference text, should provide the basis for the socioeconomic debate that will inevitably intensify with time."—Liebe F. Cavalieri, Sloan-Kettering Institute

Read more less

Book SynopsisThe 2022 edition of Rules and Guidance for Pharmaceutical Manufacturers and Distributors, known as The Orange Guide, is the essential reference for all manufacturers and distributors of medicines in the UK.

Read more less

Book SynopsisThe 2022 edition of the Rules and Guidance for Pharmaceutical Distributors, the 'Green Guide', is the essential reference for all distributors, brokers of human medicines, importers and distributors of active substances in the UK.It provides you with the single authoritative source of European good distribution practices and UK guidance, information and UK legislation on these activities.The new 5th edition has been updated to incorporate changes made after the UK's exit from the European Union on the 31st January 2020.It also incorporates new guidance on pharmacovigilance for wholesalers, the naming of sites on a licence, self-inspection, and the responsible person for import.It brings together EU guidance on good distribution practice and the MHRA's expectations for compliance. There is also a new flowchart for the registration of handling active substances

Read more less

Book Synopsis'A tour de force' – Patrick Radden Keefe, author of Empire of Pain From the doctor's office to the opioid crisis, The Hard Sell is the story of a pharmaceutical company that got Americans hooked on fentanyl – and how it was finally held to account. Now a Netflix Original Movie, Pain Hustlers, starring Emily Blunt and Chris Evans.In the early 2000s, John Kapoor had already amassed a small fortune in pharmaceuticals when he founded Insys Therapeutics. A boom time for painkillers, he had developed a novel formulation of fentanyl, the most potent opioid on the market.Kapoor, a brilliant scientist with relentless business instincts, was eager to make the most of his innovation. But there was a problem: the drug was approved only for cancer patients in dire condition. So he recruited an avaricious team, who employed a variety of deceptive techniques, from falsifying patient records to deceiving insurance companiesTrade Review'This is that rare story of the opioid crisis in which the bad guys face a genuine reckoning. I couldn't turn the pages fast enough. A tour de force.' -- Patrick Radden Keefe'A fast-paced and maddening account . . . What’s most surprising and powerful about The Hard Sell is not one company’s criminality . . . as much as how institutionalized these practices were across the modern drug industry.' * New York Times Book Review *A pacey crime caper set against the backdrop of the opioid crisis . . . When I tell you that reading “The Hard Sell” is like watching a Scorsese film, you will assume I am exaggerating. Pick it up and tell me I’m wrong * The New York Times *Vivid . . . [An] insightful account of how a company that went public in the most successful IPO of 2013 soon ended up a poster child for corporate greed * The Boston Globe *Does the world really need another book about the opioid crisis? . . . The Hard Sell by Evan Hughes proves a worthy addition to the collection. * The Washington Post *A richly reported, mesmerizing tale, and a devastating indictment of our broken pharmaceutical industry. Everyone should read this book. -- Sheelah Kolhatkar, author of Black EdgeWhen you’re running a pharma startup, how does the obvious wrong thing to do become the thing you do anyway? The Hard Sell, fascinating in the fashion of a slow-moving train wreck, is a study of corruption -- Ted Conover, author of Newjack

Read more less

Book SynopsisA medical crime story, in the vein of Empire of Pain and Bad Blood, concerned with fentanyl and drawing back the curtains in exposing the on-the-ground tactics employed in pharmaceutical sales.Trade Review'This is that rare story of the opioid crisis in which the bad guys face a genuine reckoning. I couldn't turn the pages fast enough. A tour de force.' -- Patrick Radden Keefe'A fast-paced and maddening account . . . What’s most surprising and powerful about The Hard Sell is not one company’s criminality . . . as much as how institutionalized these practices were across the modern drug industry.' * New York Times Book Review *A pacey crime caper set against the backdrop of the opioid crisis . . . When I tell you that reading “The Hard Sell” is like watching a Scorsese film, you will assume I am exaggerating. Pick it up and tell me I’m wrong * The New York Times *Vivid . . . [An] insightful account of how a company that went public in the most successful IPO of 2013 soon ended up a poster child for corporate greed * The Boston Globe *Does the world really need another book about the opioid crisis? . . . The Hard Sell by Evan Hughes proves a worthy addition to the collection. * The Washington Post *A richly reported, mesmerizing tale, and a devastating indictment of our broken pharmaceutical industry. Everyone should read this book. -- Sheelah Kolhatkar, author of Black EdgeWhen you’re running a pharma startup, how does the obvious wrong thing to do become the thing you do anyway? The Hard Sell, fascinating in the fashion of a slow-moving train wreck, is a study of corruption -- Ted Conover, author of Newjack

Read more less

Book SynopsisAward-winning journalist and New York Times bestselling author Gerald Posner reveals the heroes and villains of the trillion-dollar-a-year pharmaceutical industry and delivers ';a withering and encyclopedic indictment of a drug industry that often seems to prioritize profits over patients (The New York Times Book Review).Pharmaceutical breakthroughs such as antibiotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry. ';Gerald's dogged reporting, sets Pharma apart from all books on this subject' (The Washington Standard) as we are introduced to brilliant scientists, incorruptible government regulators, and braveTrade Review“A withering and encyclopedic indictment of a drug industry that often seems to prioritize profits over patients . . . Pharma reads like a pharmaceutical version of cops and robbers." —New York Times Book Review“New information, coupled with Gerald’s dogged reporting, sets Pharma apart from all books on this subject.” —The Washington Standard“Gerald Posner’s unsettling book, five years in the making and buttressed by a trove of documentation, is not only a careful history, it’s also a staggering indictment of pharmaceutical companies. . . . Very readable.” —Christian Science Monitor“Compelling and enraging . . . An encyclopedic act of reporting.” —Pittsburgh Post-Gazette“Explosively, even addictively, readable . . . Fraud, incompetence, conspiracy, avarice: it’s all here.” —Booklist (starred review)“You know the old saying: Timing is everything. That is certainly the case with Gerald Posner . . . . The timing of Pharma is extraordinary.” —Dallas Morning News"I could not put down Gerald Posner’s Pharma, the definitive story of how one family, the Sacklers, set out to get exquisitely rich on the back of unsuspecting Americans—then blamed the so-called 'abusers' instead of their own highly addictive drug. Posner has unearthed important new material that illuminates our national tragedy, crafting a meticulously reported page-turner that is as juicy as it is clear-eyed." —Beth Macy, New York Times bestselling author of Dopesick"A shocking, rousing condemnation of an industry clearly in need of better policing." —Kirkus "Posner has created a medical leviathan for our times." —LitHub

Read more less

Book Synopsis How does a mere moleculea chemical structurebecome a drug? And, how do we know that is works safely? In a one-trillion-dollar pharmaceutical industry with high-stakes profits and perils, battles are raging every day to successfully bring a molecule to its birth: an FDA-approved medicine. In Medicine Wars, Dr. Makhdum Ahmed, an internationally renowned expert in cancer treatment and drug development, takes readers behind the scenes of the fascinating and sometimes cutthroat world of drug development. Today, the average person takes multiple drugs or supplements daily, and for those living with chronic conditions, even 10 drugs per day are not uncommon. Yet most of us are oblivious to what drugs do to our body, or what our body does to the drugs we take. Medicine Wars reveals how drugs work, the chemistry of diseases, how decisions are made by pharmaceutical companies, how new drugs are created and introduced to patients, and the long and challenging road to FDA approval. Alon

Read more less

Book SynopsisLarge-scale, interoperable biobanks are an increasingly important asset in today's life science research and, as a result, multiple types of biobanks are being established around the globe with very different financial, organizational and legal set-ups. With interdisciplinary chapters written by lawyers, sociologists, doctors and biobank practitioners, Global Genes, Local Concerns identifies and discusses the most pressing issues in contemporary biobanking.This timely book addresses pressing questions such as: how do national biobanks best contribute to translational research?; What are the opportunities and challenges that current regulations present for translational use of biobanks?; How does inter-biobank coordination and collaboration occur on various levels?; and how could academic and industrial exploitation, ownership and IPR issues be addressed and facilitated? Identifying that biobanks foundational and operational set-ups should be legally and ethically sound, while at the same time reflecting the hopes and concerns of all the involved stakeholders, this book contributes to the continued development of international biobanking by highlighting and analysing the complexities in this important area of research.Academics in the fields of law and ethics, health law and biomedical law, as well as biobank managers and policymakers will find this insightful book a stimulating and engaging read.Contributors include: T. Bossow, T.A. Caulfield, B.J. Clark, Å. Hellstadius, J.R. Herrmann, K. Høyer, M. Jordan, J. Kaye, N.C.H. Kongsholm, K. Liddell, J. Liddicoat, M.J. Madison, T. Minssen, B. Murdoch, W. Nicholson Price II, E. Ortega-Paino, M. Prictor, M.B. Rasmussen, K. Sargsyan, J. Schovsbo, A.M. Tupasela, E. van Zimmeren, F. Vogl, H. Yu, P.K. YuTrade Review‘a valuable tool not only for researchers and policymakers, but also to legal practitioners.’ -- Peter Ling, IPkatTable of ContentsContents: Introduction Part I - Biobanks, Big Data and Modes of Collaboration 1. Big Data and the ethics of detail: the role of ethics work in the making of a cross-national research infrastructure for genetic research Klaus Hoeyer, Aaro Tupasela, Malene Bøgehus Rasmussen 2. Biobanks as Knowledge Institutions Michael J. Madison Part II - Biobanks, translational medicine and tech transfer 3. Biobanks as Innovation Infrastructure for Translational Medicine W. Nicholson Price II 4. Responsible Use of Human Biosamples in the Bioscience Industries Brian J Clark and Tina Bossow Part III - Biobanks, Human Rights and Patient Involvement 5. Biobanking, Scientific Productions and Human Rights Peter K. Yu 6. You told me, Right? - Free and Informed Consent in European Patent Law Åsa Hellstadius and Jens Schovsbo 7. Dynamic Consent and Biobanking – A Means of Fostering Sustainability? Jane Kaye and Megan Prictor 8. Generating Trust in Biobanks within the Context of Commercialization: Can Dynamic Consent Overcome Trust Challenges? Esther van Zimmeren 9. Exploitation and vulnerabilities in consent to biobank research in developing countries Nana Cecilie Halmsted Kongsholm 10. Biobanking and the Consent Problem Timothy Caulfield and Blake Murdoch Part IV - Biobanks, Guidelines and Good Governance 11. Responsible Research and Innovation and the Advancement of Biobanking and Biomedical research Helen Yu 12. Do we need an expiration date for biobanks? Franziska Vogl and Karine Sargsyan 13. Biobanks and Biobank Networks Eva Ortega-Paíno and Aaro Tupasela 14. IP Policies for Large Bioresources: the fiction, fantasy and future of openness Kathleen Liddell, Johnathan Liddicoat and Matthew Jordan Index

Read more less

Book SynopsisCollaborative Creativity is a powerful methodology for groups that uses short bursts of creative challenges to help people go beyond rational/conscious thinking and uncover, with constructive consequences, the emotional/irrational sphere that influences behaviour. It was developed by Peter Comber specifically for the complex environment of the healthcare industry, and this how-to manual for managers of healthcare companies offers practical advice on how to employ creative processes in their sector.Trade ReviewI'm not even finished with this book, and it's already clear to me that it is a 5-Star piece of writing and an incredibly practical resource.Having done considerable work with Peter Comber over the past 15 years, I can attest that he is the real deal -- and so is his book. I've seen, firsthand, how Pete gets the best thinking from groups of people, and this book shares his brilliant tips on how to capture that kind of lightning in a bottle.For anyone wanting to foster greater creativity and collaboration in their workplace, get this book. You'll be glad you did. * Amazon.com *Table of ContentsAbout the author ........................................................................ xiii Acknowledgements .........................................................................xv A brief introduction to Collaborative Creativity ................. 1 Part 1: The foundations of Collaborative Creativity ..7 The five forces of Collaborative Creativity .......................... 9 Self-discovery ............................................................................ 12 Empathy .................................................................................... 16 Invention................................................................................... 21 Realization ................................................................................ 27 Cohesion ................................................................................... 31 Five-in-one ............................................................................... 36 Making sense ..................................................................... 41 Exceptional pharma ........................................................... 47 Creativity and ideas ........................................................... 51 Part 2: How to use Collaborative Creativity .............59 Do-it-yourself .................................................................... 61 Terminology not jargon .................................................... 65 The eight principles of Collaborative Creativity ................ 69 Clearly stated objective ............................................................. 70 Rational and emotional responses ............................................ 72 Exercises are unique to each project ........................................ 74 Multiple, diverse exercises ........................................................ 76 Safe and stimulating environment ............................................ 78 Individual, team and group tasks ............................................. 81 Repetitive organizing structure ................................................. 82 Group discussion ending .......................................................... 83 The Collaborative Creativity project .................................. 85 Problem paper .......................................................................... 86 Project briefing ......................................................................... 86 Mapping .................................................................................... 87 Project statement and project design ........................................ 88 Project output ........................................................................... 92 The Collaborative Creativity session .................................. 93 Coach ........................................................................................ 94 Moderator ................................................................................. 94 Participants ................................................................................ 94 Other actors .............................................................................. 95 Collaborative Creativity session agenda .................................... 95 Designing a Collaborative Creativity session ............................ 96 Refining the session ................................................................100 Before and after the session ...................................................102 Collaborative Creativity exercises .................................... 105 Curating the flow of the exercises in a session .....................106 Inventing a creative exercise ..................................................110 Designing the worksheet and stimuli .....................................116 Collaborative Creativity exercise formats ........................ 119 Time travel ..............................................................................119 Lifebelt ....................................................................................121 Transforma ..............................................................................123 Collage ....................................................................................124 Identikit ..................................................................................127 Parallel universe ......................................................................129 Pre-session exercises ...............................................................130 Moderating ...................................................................... 133 Preparation ..............................................................................133 Session moderation .................................................................134 Deposition ...............................................................................141 Change and opportunity ................................................. 143 Quality office time .................................................................144 Mass distraction ......................................................................144 The soul in the machine ........................................................145 Signal-to-noise ratio ...............................................................146 Plastic brains ...........................................................................146 Trains and helicopters ............................................................147 Further resources ................................................................... 149 Further reading on how we think and act ............................................149 Further reading on creativity ..............................................................150

Read more less

Book SynopsisIn Pharmanomics, investigative journalist Nick Dearden digs down into the way we produce our medicines and finds that Big Pharma is failing us, with catastrophic consequences.Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financialising medicine - from Purdue's rapacious marketing of highly addictive OxyContin, through Martin Shkreli's hiking the price of a lifesaving drug, to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication.Since the 1990s, Big Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response, Dearden offers a pathway to a fairer, safer system for all.Trade ReviewNick Dearden's book is about the structural foundations of a global market in life-saving medicines. A market dependent on taxpayer subsidies, but designed to strip both rich and poor governments of the power to improve health. An essential read for those that care about saving lives, and that want the system changed. -- Ann Pettifor, author of A Case for the Green New Dealbrings together detailed investigative research with lessons from the frontlines of the fight for access to medicines. It exposes a global apartheid in which a few mostly white male Pharma bosses make billions while billions of people are left without essential medicines. It exposes how the problem of medical monopolies is not a few rule-breakers but the rules themselves. Most crucially, it shows how the system which put profits over people's lives was man-made, and how through collective action people can unmake it, for everyone's health. -- Winnie Byanyima, UNAIDS Executive Director and United Nations Under-Secretary-GeneralCarefully researched ... Despite the depressingly familiar story of greedy, rapacious capitalism, this is a hopeful book. -- Mike Phipps * Labour Hub *Authoritative, detailed, practical and written with passion ... inspiring -- Clare Sansom * East Anglia Bylines *A fascinating account of the evolution of Big Pharma into a profit-hungry monster that destructively distorts a major component of the world's healthcare systems . an enormously useful book. * Counterfire *Table of ContentsIntroduction: Bad Apples1. A History of Scandal2. A Hedge Fund with a Pharmaceutical Firm Attached3. It Was Greed, My Friends4. The Pandemic Begins5. Recolonising the Global Economy6. The Hospital That Became a Trading Floor7. A New Hope8. Reach for the Moon

Read more less

Book SynopsisThe pharmaceutical industry is broken. From the American hedge fund manager who hiked the price of an AIDS pill from $17.50 to $750 overnight to the children's cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system that was designed to drive innovation and patient care has been relentlessly distorted to drive up profits.Medicines have become nothing more than financial assets. The focus of drug research, how drugs are priced and who has access to them is now dictated by shareholder value, not the good of the public. Drug companies fixated on ever-higher profits are being fined for bribing doctors and striking secret price-gouging deals, while patients desperate for life-saving medicines are driven to the black market in search of drugs that national health services can't afford.Sick Money argues that the way medicines are developed and paid for is no longer working. Unless we take action we risk a dramatic decline in the pace of drug development and a future in which medicines are only available to the highest bidder. In this book investigative journalist Billy Kenber offers a diagnosis of an industry in crisis and a prescription for how we can fight back.Trade ReviewBilly Kenber is one of the most promising young journalists in the land, and he has, unsurprisingly, produced a compelling debut which surprises, entertains and inspires dismay. An essential read -- SATHNAM SANGHERABilly Kenber does a fantastic job, pulling apart the origins of the drugs industry and machinations of its shameless profiteers with surgical precision . . . it's quite a ride. A must-read for anyone who wants to understand how the drugs industry really does its business -- JACQUES PERETTIA forensic and very readable account of the reforms needed to make the pharmaceutical industry serve the public good as well as private profit . . . Kenber's ground-breaking investigative reporting has . . . resulted in a change in the law in the UK, intervention by regulators, cuts in the price of some medicines, life-changing benefits for patients, savings of hundreds of millions of pounds for the NHS and record fines for drug firms -- ANDREW GRICE[Sick Money] distinguishes itself from many other books by its investigative power and meticulous clarity * * The Times * *Powerful, gripping and rigorous, this book couldn't have come at a better time. Never has it been so important to delve into the tangled web behind the medicines and vaccines we all rely on. With years of research and reporting under his belt, Kenber is the perfect person to take us on this fascinating journey -- MAEVE McCLENAGHAN, author of NO FIXED ABODEA clever exploration of a scandal that affects everyone who uses - and pays for - the NHS. This is an enormously complex subject, but Kenber finds the interesting characters and fascinating details that bring the story to life. A great and important read -- HOLLY WATT, author of CASEY BENEDICT seriesA painstakingly researched and beautifully written history of the dark underbelly of the pharmaceutical industry, which never forgets to tell the stories of the vulnerable people harmed when these companies lose their moral compass. I could not put it down -- NIGEL PRAITIES, executive editor of the PHARMACEUTICAL JOURNAL

Read more less

Book SynopsisTHE PHARMACEUTICAL INDUSTRY IS BROKENFrom the American hedge fund manager who drastically hiked the price of an AIDS pill to the children's cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system built to drive innovation and improve patient care has been distorted to maximise profits.In Sick Money, the investigative journalist who exposed a billion-pound British price-hiking scandal goes inside the global battle over high drug prices. From secret deals to patients forced to turn to the black market, Billy Kenber reveals how medicines have become nothing more than financial assets. He offers a diagnosis of an industry in crisis - and a prescription for how it could be fixed.Trade ReviewBilly Kenber is one of the most promising young journalists in the land, and he has, unsurprisingly, produced a compelling debut which surprises, entertains and inspires dismay. An essential read -- SATHNAM SANGHERABilly Kenber does a fantastic job, pulling apart the origins of the drugs industry and machinations of its shameless profiteers with surgical precision . . . it's quite a ride. A must-read for anyone who wants to understand how the drugs industry really does its business -- JACQUES PERETTITerrific reporting and a lucid and clear exposé of how the drug industry too often puts profits ahead of patients -- GERALD POSNER[Sick Money] distinguishes itself from many other books by its investigative power and meticulous clarity * * The Times * *A forensic and very readable account of the reforms needed to make the pharmaceutical industry serve the public good as well as private profit . . . Kenber's ground-breaking investigative reporting has . . . resulted in a change in the law in the UK, intervention by regulators, cuts in the price of some medicines, life-changing benefits for patients, savings of hundreds of millions of pounds for the NHS and record fines for drug firms -- ANDREW GRICEPowerful, gripping and rigorous, this book couldn't have come at a better time. Never has it been so important to delve into the tangled web behind the medicines and vaccines we all rely on. With years of research and reporting under his belt, Kenber is the perfect person to take us on this fascinating journey -- MAEVE McCLENAGHAN, author of NO FIXED ABODEA clever exploration of a scandal that affects everyone who uses - and pays for - the NHS. This is an enormously complex subject, but Kenber finds the interesting characters and fascinating details that bring the story to life. A great and important read -- HOLLY WATT, author of CASEY BENEDICT seriesA painstakingly researched and beautifully written history of the dark underbelly of the pharmaceutical industry, which never forgets to tell the stories of the vulnerable people harmed when these companies lose their moral compass. I could not put it down -- NIGEL PRAITIES, executive editor of the PHARMACEUTICAL JOURNAL

Read more less

Book SynopsisIn a world that is changing, everybody in business wants to know how to achieve and maintain success. This is the case whether your business is local, national, or global, and no matter the products or services you provide. This book sets out the impressive rise of Tiens Group, which started locally, expanded nationally, and now operates globally from its headquarters in China. The book provides not only an analysis of the factors that have contributed to the success, but also sets out examples of how these factors can be adapted to other business enterprises. In this book, you will discover deep insight into how notions such as swap and transcendence assist in business development, a sense of how Chinese businesses have developed across the world, and an understanding of how both clear focus and an ability to adapt are critical to business success.

Read more less

Book SynopsisThe present publication provides a comprehensive examination of animal biotechnology and its various applications in veterinary medicine and pharmaceuticals, as well as in the improvement of animal feed production. Transgenic technologies have been utilized to enhance milk production and meat production in farm animals, as well as to establish models for human diseases. Transgenic animals are also employed for the production of proteins for medical use in humans. Biotechnology has been utilized to facilitate xenotransplantation from animals to humans. Genetic engineering has been performed on farm animals, and nuclear transfer technology has become an essential and favored method for cloning animals. Biotechnology has the potential to be utilized in the management of various animal diseases, including foot-and-mouth disease, classical swine fever, avian influenza, and bovine spongiform encephalopathy. The most significant biotechnology-based products comprise vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases in pet animals is a rapidly developing field, as many of the technologies employed in clinical trials with humans were first developed in animals, and many of the diseases in cats and dogs are similar to those in humans. RNA interference technology is now being used in research related to veterinary medicine. Molecular diagnosis is playing an increasingly significant role in veterinary practice. Polymerase chain reaction and its modifications are considered to be essential. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way into veterinary diagnostics. This book attempts to unravel the mysteries of biotechnology as it pertains to animal health and production.

Read more less

Book SynopsisThis book offers undergraduate and postgraduate students fundamental protocols in an accessible and simplified manner. The book encompasses experiments from every area of biotechnology and serves as an essential resource for researchers in this field. The manual emphasizes the inclusion of essential and basic protocols, offering readers valuable, first-hand information about biotechnology research.

Read more less

Book SynopsisIn contemporary times, crop improvement has emerged as a multidisciplinary domain of agriculture. This book, entitled Breeding, Biotechnology, and Seed Production of Field Crops, places emphasis on the principles, methods, and practices of plant breeding, biotechnology in crop improvement, and seed production of field crops. This book has been written for a diverse audience, including learners, educators, and staff members of the seed industry. It holds particular significance for postgraduate students specializing in plant breeding and seed science. The content has been designed according to the syllabus recommended by the Indian Council of Agricultural Research for postgraduate students at various agricultural universities across the country. The book is divided into two main sections: i) Principles of crop breeding, and ii) Methods and practices of crop improvement and seed production for individual field crops. It contains a total of 18 chapters, with the first three chapters focusing on basic principles, and the remaining chapters detailing the methods and practices for individual crops. We hope that this book will be a valuable resource for advanced undergraduate students pursuing plant breeding as an elective, postgraduate students who have chosen plant breeding as their area of specialization, teachers, researchers, and staff members of private seed companies in this field.

Read more less

Book SynopsisThis book is entirely devoted to the subject of DNA and aims to reveal its secrets in an accessible and straightforward manner. It is an invaluable resource for those in the field of bioscience, comprising a total of twelve chapters, along with figures, photographs, and a comprehensive glossary of DNA-related terms.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisBiotechnology: laboratory manual provides basic protocols required for students of undergraduate and postgraduate programme. The protocols are explained in a simplified manner and are very easy to conduct. The book is a collection of experiments from all fields of biotechnology and will become a companion for all those who do research in the field of biotechnology. Attention is given to include most of the basic protocols. This book will provide first hand valuable information for all those who are interested in biotechnology research.Table of ContentsSection I - Units of measurements: 01. Different units used in measurements 02. Solution preparation Section II - Biotechnology laboratory: 03. General precautions and requirements 04. Equipments 05. Principles of some common instruments Section III - Biochemistry: 06. Biochemical preparations 07. Biochemical estimations 08. Biochemical separations Section IV - Enzymes: 09. Enzymes 10. Enzyme assays 11. Enzyme extraction Section V - Microbiology: 12. General microbiology 13. Media preparation Section VI - Plant biotechnology: 14. Plant tissue culture 15. Plant molecular biology Section VII - Animal biotechnology: 16. General requirements and experiments in animal biotechnology 17. Animal cell culture 18. Embryonic stem ES cells Section VIII - Molecular biology: 19. General molecular biology procedures

Read more less

Book SynopsisThe GHS addresses classification of chemicals by types of hazard and proposes harmonised hazard communication elements, including labels and safety data sheets. It aims at ensuring that information on physical hazards and toxicity from chemicals be available in order to enhance the protection of human health and the environment during the handling, transport and use of these chemicals. It also provides a basis for harmonisation of rules and regulations on chemicals at national, regional and worldwide levels, an important factor also for trade facilitation

Read more less

Book SynopsisThis book describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in animal food production. Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals. Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flue and bovine spongiform encephalopathy. The most important biotechnology based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans. RNA interference technology is now being applied for research in veterinary medicine. Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics. This book is an attempt to unravel the mysteries of biotechnology as it affects animal health and production."Table of Contents1. Introduction to biotechnology 2. Biotechnology in animal production 3. Role of biotechnology in animal health 4. Modern biotechnology issues 5. Information sources and requirements for a biotechnology laboratory 6. Present status and future prospects of biotechnology in animal health and production 7. Biotechnology research in India. 08. Techniques used in a biotechnology laboratory

Read more less

Book SynopsisAll undergraduate and postgraduate students of science and engineering faculties will be benefited by this book. It is meant for all undergraduate and postgraduate students of civil engineering science faculty and geology irrespective of their specializations. This book is based mainly on a course of lectures prepared to cover the syllabus of engineering geology course in Universities all over the country. The book will be useful for Civil Engineering students of other universities also. The engineering geology portion of the book also covers the engineering geology included in the B.Sc, M. Sc and M. Tech courses in geology and the book will meet the requirements of students of geology as far as engineering geology is concerned like practicing engineers who need a simple introduction to the principles of geology which are important from the point of view of engineering will get them in this book."Table of ContentsSection 1. Introduction Section 2. Physical geology Section 3. Mineralogy Section 4. Peterology Section 5. Structural geology Section 6. Tectonics Section 7. Engineering geology

Read more less

Book SynopsisIn modern days, crop improvement is a multidisciplinary division of agriculture. In this book, entitled, "Breeding, Biotechnology and Seed Production of Field Crops", emphasis has been given on principles, methods and practices in plant breeding, biotechnology in crop improvement and seed production of field crops. The book has been written for all sections of learners, educators and staff-members of seed industries. Particular importance has been underlined for postgraduate students who specialize in plant breeding and seed science. Each of the book has been designed as per the recommended of syllabus of Indian Council of Agricultural Research for the postgraduate students of various Agricultural Universities in our country. This book has been divided into two major parts- i) Principles of crop breeding and ii) Methods and practices of crop improvement and seed production of individual field crop. The book contains total of 18 chapteFirst three s are related to shed light on the basic-principles and remaining s deal with methods and practices of individual crop for improvement and seed production. We hope that the book will be ready to lend a hand to the advanced undergraduate students doing plant breeding in elective, postgraduate students who opted plant breeding, teachers, researchers and staff-members of private seed companies of this field of specialization.Table of Contents01. History of Crop Improvement in India by Bidhan Roy, Sanjib Bhadra, Basu AK 02. Pollination Biology for Crop Improvement and Crop Production by Bidhan Roy, Venkateshwarlu Challa, Basu AK 03. Heterosis Breeding by Saha BC 04. Rice (Oryza sativa L.) by Vijay D., Bidhan Roy 05. Aromatic Rice of India (Oryza sativa L.) by Bidhan Roy, Basu AK 06. Hybrid Rice in Tropical Countries by Bidhan Roy, D. Vijay 07. Wheat (Triticum aestivum) by Saikat Das 08. Achievement and Letdown in Hybrid Wheat by Bidhan Roy, Basudeb Sarkar 09. Maize (Zea mays L.) by Rajashekhar MK, Salimath PM, Wali, MC 10. Hybrid Maize by Rajashekhar MK, Salimath PM, Wali, MC 11. Sorghum (Sorghum bicolor) by A Ashok Kumar, Belum VS Reddy, P Sanjana Reddy, S Ramesh, P Srinivasa Rao and Ch Ravinder Reddy 12. Sorghum Hybrid Technology by Belum VS Reddy, A Ashok Kumar , Ch Ravinder Reddy and Vilas A Tonapi 13. Pearl Millet (Pennisetum glaucum) by Khairwal IS, Rajpurohit BS, Sangeeta Kumari 14. Barley (Hordeum vulgare L.) by Basudeb Sarkar, Bidhan Roy, Kharub AS, Selvakumar R, Dinesh Kumar, Verma RPS, Indu Sharma 15. Finger Millet (Eleusine coracana Gaertn.) by Rajendra Prasad S, Shanthala J, Siddaraju R 16. Small Millets by Sabesan T 17. Yam Bean (Pachyrhizus erosus) by Bidhan Roy 18. Intellectual Property Rights and Regulations for Crop Plants by Bidhan Roy

Read more less